OAS1 and COVID-19: We investigated our recently published PBMC scRNA-seq data22 obtained from 112 donors, including 84 COVID-19-positive individuals, and profiled using the CITE-seq approach39, as an independent in vivo validation of OAS1 eQTL colocalization with GWAS locus for COVID-19 susceptibility (Methods).